Why should topical azithromycin be discontinued in contact lens wear?

Study for the NBEO Part II TMOD Exam. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

Why should topical azithromycin be discontinued in contact lens wear?

Explanation:
The key idea is the preservative in the eye drop. Topical azithromycin formulations use benzalkonium chloride (BAK) as a preservative, and this compound can be toxic to the corneal surface with repeated exposure. Soft contact lenses readily absorb BAK, acting like a reservoir that concentrates the preservative and then releases it onto the eye, increasing irritation, surface toxicity, and lens intolerance. Because of this lens-related toxicity risk, discontinuing use during contact lens wear is advised. The other possibilities described aren’t the main issue here—rapid corneal melt, elevated intraocular pressure, or lack of antimicrobial activity aren’t typical concerns with azithromycin in lens wear.

The key idea is the preservative in the eye drop. Topical azithromycin formulations use benzalkonium chloride (BAK) as a preservative, and this compound can be toxic to the corneal surface with repeated exposure. Soft contact lenses readily absorb BAK, acting like a reservoir that concentrates the preservative and then releases it onto the eye, increasing irritation, surface toxicity, and lens intolerance. Because of this lens-related toxicity risk, discontinuing use during contact lens wear is advised. The other possibilities described aren’t the main issue here—rapid corneal melt, elevated intraocular pressure, or lack of antimicrobial activity aren’t typical concerns with azithromycin in lens wear.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy